Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Class action filed
Acq. announced
Consulting agrmnt
Quarterly results
Director departure
Appointed director
CC transcript

ERESEARCHTECHNOLOGY INC (ERES) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/08/2012 SC 13G/A ERESEARCHTECHNOLOGY INC reports a
07/13/2012 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
07/13/2012 EFFECT Form EFFECT - Notice of Effectiveness
07/13/2012 EFFECT Form EFFECT - Notice of Effectiveness
07/09/2012 8-K Quarterly results
07/09/2012 8-K Entered into consulting agreement
Docs: "Agreement and Plan of Merger, by and among invivodata, Inc., Explorer Holdings, Inc., eResearchTechnology, Inc. (as successor to Explorer Acquisition Corp.), Impact Acquisition Corp. and Fortis Advisors LLC",
"Amended and Restated Certificate of Incorporation of eResearchTechnology, Inc",
"Amended and Restated Bylaws of eResearchTechnology, Inc",
"Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT , a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations , announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction valued at approximately $400 million. Dr. Jeffrey Litwin, who will continue to lead ERT as CEO, said, “As a private company we will continue to serve our customers and enhance our suite of products. We have been able to grow our company into a global leader, and, with Genstar's partnership, we will look for creative new ways to grow our business organically and identify new investment opportunities as part of our continued develo...",
"ERT Acquires invivodata to Establish the Industry's Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations , announced today the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes solutions and PRO Consulting services, based in Pittsburgh, PA. The transaction was facilitated by the San Francisco-based private equity group, Genstar Capital, LLC who last week announced that they had completed the acquisition of ERT. The acquisition immediately positions ERT as a leader in Clinical Outcome Assessments . The combined organization will now offer sponsors, CROs and ot..."
07/06/2012 4 Scheppmann Stephen Mark (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 9,643 shares @ $8, valued at $77.1k
Disposed/sold 10,870 options to buy @ $6.21, valued at $67.5k
Disposed/sold 9,212 options to buy @ $7.37, valued at $67.9k
Disposed/sold 22,000 options to buy @ $4.6, valued at $101.2k
07/06/2012 4 SCHNECK KEITH D (Exec VP, CFO & Secretary) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 19,045 shares @ $0
Disposed/sold 34,968 shares @ $8, valued at $279.7k
Disposed/sold 38,835 options to buy @ $6.46, valued at $250.9k
Disposed/sold 38,759 options to buy @ $6.05, valued at $234.5k
Disposed/sold 75,000 options to buy @ $4.6, valued at $345k
07/06/2012 4 PHILLIPS STEPHENS S (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 193,503 shares @ $8, valued at $1.5M
Disposed/sold 10,870 options to buy @ $6.21, valued at $67.5k
Disposed/sold 9,212 options to buy @ $7.37, valued at $67.9k
Disposed/sold 22,000 options to buy @ $4.6, valued at $101.2k
Disposed/sold 45,000 options to buy @ $6.29, valued at $283.1k
07/06/2012 4 MORGANROTH JOEL M D (Exec VP, Chief Scientific Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 19,068 shares @ $0
Disposed/sold 1,258,974 shares @ $8, valued at $10.1M
Disposed/sold 80,097 options to buy @ $6.46, valued at $517.4k
Disposed/sold 43,253 options to buy @ $6.05, valued at $261.7k
Disposed/sold 70,000 options to buy @ $4.6, valued at $322k
Disposed/sold 30,000 options to buy @ $7.41, valued at $222.3k
Disposed/sold 90,000 options to buy @ $6.29, valued at $566.1k
07/06/2012 4 HITCHNER ELAM M III (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 17,143 shares @ $8, valued at $137.1k
Disposed/sold 10,870 options to buy @ $6.21, valued at $67.5k
Disposed/sold 9,212 options to buy @ $7.37, valued at $67.9k
Disposed/sold 22,000 options to buy @ $4.6, valued at $101.2k
07/06/2012 4 FAICH GERALD A (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 41,643 shares @ $8, valued at $333.1k
Disposed/sold 10,870 options to buy @ $6.21, valued at $67.5k
Disposed/sold 9,212 options to buy @ $7.37, valued at $67.9k
07/06/2012 4 Besier Klaus P (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 10,570 shares @ $8, valued at $84.6k
Disposed/sold 10,870 options to buy @ $6.21, valued at $67.5k
Disposed/sold 11,130 options to buy @ $6.09, valued at $67.8k
07/06/2012 4 LITWIN JEFFREY S (President & CEO) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 43,644 shares @ $0
Disposed/sold 192,947 shares @ $8, valued at $1.5M
Disposed/sold 31,327 options to buy @ $6.21, valued at $194.5k
Disposed/sold 35,437 options to buy @ $6.46, valued at $228.9k
Disposed/sold 36,456 options to buy @ $6.05, valued at $220.6k
Disposed/sold 50,000 options to buy @ $4.6, valued at $230k
Disposed/sold 20,000 options to buy @ $7.41, valued at $148.2k
Disposed/sold 52,500 options to buy @ $6.29, valued at $330.2k
07/06/2012 4 Schuelke Achim (Exec VP, Chief Technology Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 14,760 shares @ $0
Disposed/sold 1,979 shares @ $8, valued at $15.8k
Disposed/sold 10,797 shares @ $8, valued at $86.4k
Disposed/sold 50,097 options to buy @ $6.46, valued at $323.6k
Disposed/sold 75,000 options to buy @ $7.94, valued at $595.5k
07/06/2012 4 FURLONG AMY (Exec VP, Chief Operations Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 16,188 shares @ $0
Disposed/sold 7,380 shares @ $8, valued at $59k
Disposed/sold 19,031 shares @ $8, valued at $152.2k
Disposed/sold 33,010 options to buy @ $6.46, valued at $213.2k
Disposed/sold 30,104 options to buy @ $6.05, valued at $182.1k
Disposed/sold 50,000 options to buy @ $4.6, valued at $230k
Disposed/sold 20,000 options to buy @ $7.41, valued at $148.2k
Disposed/sold 11,250 options to buy @ $6.29, valued at $70.8k
Disposed/sold 5,625 options to buy @ $3.01, valued at $16.9k
07/06/2012 4 DEVINE THOMAS P (Exec VP, Chief Information Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/
Txns: Disposed/sold 15,474 shares @ $0
Disposed/sold 10,000 shares @ $8, valued at $80k
Disposed/sold 24,740 shares @ $8, valued at $197.9k
Disposed/sold 31,553 options to buy @ $6.46, valued at $203.8k
Disposed/sold 28,547 options to buy @ $6.05, valued at $172.7k
Disposed/sold 50,000 options to buy @ $4.6, valued at $230k
Disposed/sold 20,000 options to buy @ $7.41, valued at $148.2k
Disposed/sold 43,688 options to buy @ $6.29, valued at $274.8k
Disposed/sold 17,375 options to buy @ $4.21, valued at $73.1k
07/03/2012 POS AM Form POS AM - Post-Effective amendments for registration statement
07/03/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/03/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/03/2012 POS AM Form POS AM - Post-Effective amendments for registration statement
07/03/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/03/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/03/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/03/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/12/2012 8-K Class action lawsuit filed
05/21/2012 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
05/07/2012 10-Q Quarterly Report for the period ended March 31, 2012
05/07/2012 8-K Quarterly results
Docs: "ERT Reports First Quarter 2012 Operating Results"
05/04/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
04/30/2012 10-K/A Annual Report for the period ended December 31, 2011 [amend]
04/11/2012 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/10/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy